Company Profile

Avidity LLC
Profile last edited on: 12/20/06      CAGE: 47RC7      UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1899 Gaylord Street
Denver, CO 80206
   (303) 320-6063
Location: Single
Congr. District: 01
County: Denver

Public Profile

Avidity holds exclusive rights to the patented biotin-accepting peptides (AviTag) technology. Currently, this technology is licensed by 7 out of the top 10 leading pharmaceutical companies and is used by researchers in 22 countries. AviTag technology exploits the tight interaction of avidin or streptavidin with biotin for immobilizing, purifying and visualizing proteins. Immobilized AviTag-fusion proteins are used for applications ranging from high-throughput screening (HTS) to protein-protein interactions using surface plasmon resonance. Purification of AviTag-fusion proteins using monomeric avidin can be more efficient than the commonly used hexa-HIS or Strep-tag® technologies (Tucker and Grishammer) and AviTag-fusion proteins can be visualized using avidin or streptavidin conjugates such as Western Blots and MHC tetramers for staining and sorting T cells.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2005 1 NIH $100,000
Project Title: Extremely Stable and Bright Periphylla Luciferase
2004 1 NIH $102,000
Project Title: Hepatitis C Virus Protein Microarrays
2001 1 NIH $99,750
Project Title: Peptide For Gentle Purification Of Biotinylated Protein

Key People / Management

  Naushad Ali

  Millard G Cull

  Ronald E Gill

  Larry Lansing

Company News

There are no news available.